HUM · Insider Trading
Humana Inc.
Every open-market purchase and sale reported by HUM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Kurt J Hilzinger | Director | A | — | — |
| 2026-09-03 | Shantanu Nundy | Chief Medical Officer | A | +2,549 | — |
| 2026-08-04 | Frederick John Crawford | Director | A | +544 | — |
| 2026-08-04 | Paul John Smith | Director | A | +544 | — |
| 2026-07-02 | Kurt J Hilzinger | Director | A | — | — |
| 2026-05-05 | Aaron Martin | President, Medicare Advantage | A | +8,206 | — |
| 2026-05-05 | Sanjay K Shetty | President, CenterWell | A | +9,945 | — |
| 2026-05-05 | Joseph C Ventura | Chief Legal Officer | A | +10,318 | — |
| 2026-05-05 | Robert Stuart Field | Director | A | +852 | — |
| 2026-05-05 | Michelle A. O'Hara | Chief Human Resources Officer | A | +10,485 | — |
| 2026-05-05 | James A. Rechtin | President & CEO | A | +35,633 | — |
| 2026-05-05 | David Dintenfass | President, Enterprise Growth | A | +11,273 | — |
| 2026-05-05 | Japan Mehta | Chief Information Officer | A | +9,448 | — |
| 2026-05-05 | Celeste Mellet | Chief Financial Officer | A | −15,387 | — |
| 2026-04-03 | Sanjay K Shetty | President, CenterWell | MIXED | +486 | −$70.35K |
| 2026-04-02 | Kurt J Hilzinger | Director | A | — | — |
| 2026-04-02 | George Renaudin II | President, Insurance | J | — | — |
| 2026-02-26 | George Renaudin II | President, Insurance | MIXED | +616 | −$74.19K |
| 2026-02-26 | Joseph C Ventura | Chief Legal Officer | MIXED | +557 | −$84.64K |
| 2026-02-25 | Sanjay K Shetty | President, CenterWell | Buy | +810 | +$150.02K |
| 2026-02-25 | John-Paul W. Felter | SVP, Chief Accting Off & Cont. | MIXED | +5,750 | −$14.87K |
| 2026-02-24 | David Dintenfass | President, Enterprise Growth | MIXED | +2,676 | −$224.17K |
| 2026-02-18 | Celeste Mellet | Chief Financial Officer | MIXED | +3,559 | −$762.85K |
| 2026-02-18 | Japan Mehta | Chief Information Officer | MIXED | +1,252 | −$78.03K |
| 2026-02-17 | Aaron Martin | President, Medicare Advantage | A | +17,031 | — |
| 2026-01-12 | James A. Rechtin | President & CEO | MIXED | +1,203 | −$273.56K |
| 2026-01-05 | Michelle A. O'Hara | Chief Human Resources Officer | MIXED | +1,260 | −$282.94K |
| 2026-01-05 | Raquel C. Bono | Director | A | — | — |
| 2026-01-05 | Gordon Smith | Director | A | — | — |
| 2026-01-05 | Karen Katz | Director | A | — | — |
| 2026-01-05 | Kurt J Hilzinger | Director | A | — | — |
| 2026-01-05 | Jorge S. Mesquita | Director | A | +766 | — |
| 2026-01-05 | Frank A Damelio | Director | A | — | — |
| 2026-01-05 | Marcy S Klevorn | Director | A | — | — |
| 2026-01-05 | John W Garratt | Director | A | — | — |
| 2026-01-05 | Wayne A.I. Frederick | Director | A | — | — |
| 2026-01-05 | David T Feinberg | Director | A | +766 | — |
| 2025-12-17 | John-Paul W. Felter | SVP, Chief Accting Off & Cont. | MIXED | +308 | −$70.78K |
| 2025-12-17 | George Renaudin II | President, Insurance | MIXED | +1,494 | −$262.59K |
| 2025-12-17 | Joseph C Ventura | Chief Legal Officer | MIXED | +1,309 | −$296.36K |
| 2025-12-17 | James A. Rechtin | President & CEO | MIXED | +4,335 | −$910.96K |
| 2025-12-17 | Michelle A. O'Hara | Chief Human Resources Officer | MIXED | +769 | −$170.74K |
| 2025-12-17 | Sanjay K Shetty | President, CenterWell | MIXED | +1,249 | −$277.45K |
| 2025-12-17 | David Dintenfass | President, Enterprise Growth | MIXED | +1,114 | −$248.00K |
| 2025-12-17 | Japan Mehta | Chief Information Officer | MIXED | +724 | −$126.97K |
| 2025-12-17 | Celeste Mellet | Chief Financial Officer | MIXED | +906 | −$330.13K |
| 2025-11-04 | Gordon Smith | Director | M | +765 | — |
| 2025-10-03 | George Renaudin II | President, Insurance | MIXED | +369 | −$60.75K |
| 2025-10-02 | Gordon Smith | Director | A | — | — |
| 2025-10-02 | Kurt J Hilzinger | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| James A. Rechtin | President & CEO | 67,631 | $28.77M |
| Celeste Mellet | Chief Financial Officer | 39,637 | $16.86M |
| Frank A Damelio | Director | 31,852 | $13.55M |
| Joseph C Ventura | Chief Legal Officer | 27,699 | $11.78M |
| David Dintenfass | President, Enterprise Growth | 25,407 | $10.81M |
| Aaron Martin | President, Medicare Advantage | 25,237 | $10.74M |
| Susan M Diamond | Chief Financial Officer | 22,384 | $9.52M |
| Sanjay K Shetty | President, CenterWell | 22,088 | $9.40M |
| Michelle A. O'Hara | Chief Human Resources Officer | 20,026 | $8.52M |
| Kurt J Hilzinger | Director | 19,448 | $8.27M |
| Japan Mehta | Chief Information Officer | 17,176 | $7.31M |
| George Renaudin II | President, Insurance | 16,617 | $7.07M |
| Samir Deshpande | Chief Information Officer | 13,639 | $5.80M |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 13,447 | $5.72M |
| Timothy S. Huval | Chief Administrative Officer | 8,181 | $3.48M |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 7,403 | $3.15M |
| Jorge S. Mesquita | Director | 4,975 | $2.12M |
| Shantanu Nundy | Chief Medical Officer | 2,549 | $1.08M |
| John W Garratt | Director | 1,685 | $716.83K |
| David T Feinberg | Director | 1,207 | $513.48K |
| Brad D Smith | Director | 1,169 | $497.32K |
| Robert Stuart Field | Director | 852 | $362.46K |
| Gordon Smith | Director | 765 | $325.45K |
| Karen Katz | Director | 590 | $251.00K |
| Frederick John Crawford | Director | 565 | $240.36K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HUM quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.